This episode covers key insights from the J.P. Morgan Healthcare Conference, where non-profit health systems focused on operational efficiency, strategic growth in pediatrics and outpatient care, and AI investments, while enhanced security reflected the impact of the UnitedHealthcare CEO shooting. The episode also discusses rising bankruptcies among PE-owned healthcare companies, semaglutide being selected for Medicare drug price negotiations under the Trump administration, and new DEA rules that could challenge virtual-only telehealth models while benefiting hybrid care providers.
